ロード中...
High rates of medication adherence in patients with pulmonary arterial hypertension: An integrated specialty pharmacy approach
Phosphodiesterase-5 inhibitors (PDE-5I) have demonstrated improvement in disease symptoms and quality of life for patients with pulmonary arterial hypertension (PAH). Despite these benefits, reported adherence to PDE-5I therapy is sub-optimal. Clinical pharmacists at an integrated practice site are...
保存先:
| 出版年: | PLoS One |
|---|---|
| 主要な著者: | , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Public Library of Science
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6553732/ https://ncbi.nlm.nih.gov/pubmed/31170217 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0217798 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|